Gufic Biosciences faces ₹15.64 lakh penalty; plans appeal.

Gufic Biosciences Limited has received an order under Section 74 of the CGST Act, 2017, and UPGST Act, 2017, along with Section 20 of the IGST Act, 2017. The order imposes a penalty of ₹15,35,080 for ...

Gufic Biosciences Limited has received an order under Section 74 of the CGST Act, 2017, and UPGST Act, 2017, along with Section 20 of the IGST Act, 2017. The order imposes a penalty of ₹15,35,080 for alleged excess Input Tax Credit (ITC) claimed and a penalty of ₹28,972 for short payment of tax liability. The penalties are related to the financial years 2018-19 to 2022-23. The company has stated that it is not satisfied with the order and intends to file an appeal before the concerned authority. Gufic Biosciences confirms that this intimation has no material impact on its financial operations or other activities. The order was dated December 26, 2025, and received by the company via email on December 27, 2025. The authority issuing the order is the Office of the Superintendent CGST, Range-07, Division II, Ghaziabad.

Limitations of AI summaries

AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.

Platforms like Prysm provide stock-level and portfolio-level analysis.

Why is Gufic Biosciences Limited in the news today?

Gufic Biosciences Limited (GUFICBIO) is in the news due to the company received a penalty but plans to appeal, and states it will not materially impact operations. the outcome of the appeal is uncertain.

Other Regulatory FilingsLitigation Updates
Gufic Biosciences LimitedGUFICBIOhttps://prysm.fi/v2/analyze/GUFICBIO

AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

Gufic Biosciences faces ₹15.64 lakh penalty; plans appeal.

December 27, 2025, 04:46 PM

AI Sentiment Analysis

Top Queries to Ask About Gufic Biosciences Limited

Gufic Biosciences Limited has received an order under Section 74 of the CGST Act, 2017, and UPGST Act, 2017, along with Section 20 of the IGST Act, 2017. The order imposes a penalty of ₹15,35,080 for alleged excess Input Tax Credit (ITC) claimed and a penalty of ₹28,972 for short payment of tax liability.

The penalties are related to the financial years 2018-19 to 2022-23. The company has stated that it is not satisfied with the order and intends to file an appeal before the concerned authority. Gufic Biosciences confirms that this intimation has no material impact on its financial operations or other activities. The order was dated December 26, 2025, and received by the company via email on December 27, 2025. The authority issuing the order is the Office of the Superintendent CGST, Range-07, Division II, Ghaziabad.

See What Deep Dive Gives You — in Seconds

“what happens when you click Deep Dive “

Instant AI Summary - “Get clean, noise-free earnings breakdowns.”

PDF Insights - “Download detailed, AI-generated reports.”

Metrics Explained -“Key ratios & trends explained in simple language.”

Want to know if this news pushes your stock up or down?

Just tap

deep dive

More News on Gufic Biosciences Limited

Discover more trending news on Prysm

View All